MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ehf2.13772

Медицинская библиотека · ESC heart failure · 2022

Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis.

Chiarito Mauro, Sanz-Sanchez Jorge, Pighi Michele, Cannata Francesco, Rubbio Antonio Popolo, Munafò Andrea, Cao Davide, Roccasalva Fausto, Pini Daniela, Pagnotta Paolo A, Ettori Federica, Petronio Anna Sonia, Tamburino Corrado, Reimers Bernhard, Colombo Antonio, Di Mario Carlo, Grasso Carmelo, Mehran Roxana, Godino Cosmo, Stefanini Giulio G

МетаанализСистематический обзорСтатьяПеревод пока не подготовлен

Аннотация

AIM: Randomized controlled trials comparing the use of the MitraClip device in addition to guideline directed medical therapy (GDMT) to GDMT alone in patients with secondary mitral regurgitation (MR) have shown conflicting results. However, if these differences could be due to the underlying MR aetiology is still unknown. Therefore, we aimed to evaluate if the effects of percutaneous edge-to-edge repair with MitraClip implantation could differ in patients with ischaemic (I-MR) and non-ischaemic mitral regurgitation (NI-MR).

METHODS AND

RESULTS

PubMed, Embase, BioMed Central, and the Cochrane Central Register of Controlled Trials were searched for all studies including patients with secondary MR treated with the MitraClip device. Data were pooled using a random-effects model. Primary endpoint was the composite of all-cause death and heart failure-related hospitalization. Secondary endpoints were the single components of the primary endpoint, New York Heart Association functional Classes III and IV, and mitral valve re-intervention. Seven studies enrolling 2501 patients were included. Patients with I-MR compared with patients with NI-MR had a similar risk of the primary endpoint (odds ratio: 1.17; 95% confidence interval: 0.93 to 1.46; I2 : 0%). The risk of all-cause death was increased in patients with I-MR (odds ratio: 1.31; 95% confidence interval: 1.07 to 1.62; I2 : 0%), while no differences were observed between the two groups in terms of the other secondary endpoints.

CONCLUSIONS

The risk of mortality after MitraClip implantation is lower in patients with NI-MR than in those with I-MR. No absolute differences in the risk of heart failure related hospitalization were observed between groups.

Для цитирования: Chiarito Mauro, Sanz-Sanchez Jorge, Pighi Michele, Cannata Francesco, Rubbio Antonio Popolo, Munafò Andrea, Cao Davide, Roccasalva Fausto, Pini Daniela, Pagnotta Paolo A, Ettori Federica, Petronio Anna Sonia, Tamburino Corrado, Reimers Bernhard, Colombo Antonio, Di Mario Carlo, Grasso Carmelo, Mehran Roxana, Godino Cosmo, Stefanini Giulio G. Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis.. ESC heart failure. 2022. DOI: 10.1002/ehf2.13772.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.